 These substances were subject to a separate prioritization assessment and accordingly evaluated.Health Canada and Environment Canada share responsibility for conducting risk assessments of new biotechnology products (including micro-organisms) that are not subject to a pre-manufacture toxicity assessment under other federal legislation.Under the "Act", both naturally occurring and genetically modified organisms are evaluated under the "New Substances Notification Regulations (Organisms)".